CCM chief defends demerger exercise


KUALA LUMPUR: Chemical Company of Malaysia Bhd’s (CCM) head honcho has defended the company’s demerger exercise as one that will not result in any losses to shareholders.

Speaking to reporters at a briefing here yesterday, CCM group managing director Leonard Ariff Abdul Shatar acknowledged that it would take time for the market to digest the recently announced corporate exercise to de-gear and demerge from its profit-making pharmaceutical unit CCM Duopharma Biotech Bhd.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Business , CCM , CCM Duopharma , demerger , stock , shares ,

   

Next In Business News

China's exports and imports return to growth, signalling demand recovery
Hong Kong and Saudi Arabia explore funds to track Hong Kong stock indices
Oil rises on US crude storage draw, China imports show year-on-year gain
FBM KLCI retreats to 1,600
Volkswagen to establish Malaysia as export hub - Tengku Zafrul
Microsoft's staggering investment a technological shot in the arm for Malaysia
More job replenishment opportunities for Kerjaya Prospek
Philippines Q1 GDP grows 5.7% y/y
Ringgit opens easier against US$ ahead of OPR decision
FBM KLCI drifts as investors await fresh leads

Others Also Read